1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with deferoxamine in 9 studies
| Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (deferoxamine) | Trials (deferoxamine) | Recent Studies (post-2010) (deferoxamine) |
|---|---|---|---|---|---|
| 9,156 | 187 | 552 | 6,703 | 240 | 1,266 |
| Protein | Taxonomy | 1-hexadecyl-2-acetyl-glycero-3-phosphocholine (IC50) | deferoxamine (IC50) |
|---|---|---|---|
| Lysine-specific demethylase 4A | Homo sapiens (human) | 3.275 | |
| Deoxyhypusine hydroxylase | Homo sapiens (human) | 5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (77.78) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Analouei, AR; Corcoran, PC; Foegh, ML; Katz, NM; Rajan, SS; Wallace, RB; Wang, Y | 1 |
| Arfors, KE; Granger, DN; Kubes, P | 1 |
| Jamieson, WR; Poostizadeh, A; Qayumi, AK | 1 |
| Duane, P; Moldow, CF; Severson, SP; Vercellotti, GM | 1 |
| Duncker, HP; Heller, A; Koch, T; Neuhof, H; Schaible, R; van Ackern, K | 1 |
| Badosa, F; Bulbena, O; Closa, D; Fernández-Cruz, L; Gelpi, E; Hotter, G; Morris, M; Pi, F; Roselló-Catafau, J | 1 |
| Ekiz, F; Fincan, K; Haklar, G; Köksoy, F; Soybir, G; Yalçin, O; Yüksel, M | 1 |
| Cui, XF; Hatakeyama, M; Imaizumi, T; Kimura, D; Kumagai, M; Matsumiya, T; Sakaki, H; Sato, Y; Satoh, K; Shibata, T; Tamo, W; Tanji, K; Yoshida, H | 1 |
| Hatakeyama, M; Imaizumi, T; Ishikawa, A; Kimura, H; Metoki, N; Sakaki, H; Sato, Y; Satoh, K; Taima, K; Tanji, K; Yamashita, K; Yoshida, H | 1 |
9 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and deferoxamine
| Article | Year |
|---|---|
Platelet activating factor antagonist enhances lung preservation in a canine model of single lung allotransplantation.
Topics: Adenosine; Allopurinol; Animals; Deferoxamine; Diterpenes; Dogs; Ginkgolides; Glutathione; Insulin; Lactones; Lung; Lung Transplantation; Male; Organ Preservation; Organ Preservation Solutions; Platelet Activating Factor; Raffinose; Reperfusion Injury; Solutions; Tissue Preservation | 1992 |
Platelet-activating factor-induced mucosal dysfunction: role of oxidants and granulocytes.
Topics: Animals; Catalase; Cats; Deferoxamine; Granulocytes; Ileum; Intestinal Absorption; Intestinal Mucosa; Muscle, Smooth; Peroxidase; Platelet Activating Factor; Recombinant Proteins; Superoxide Dismutase | 1991 |
Effects of platelet-activating factor antagonist CV-3988 in preservation of heart and lung for transplantation.
Topics: Animals; Carbon Dioxide; Deferoxamine; Extravascular Lung Water; Female; Heart-Lung Transplantation; Hemodynamics; Organ Preservation; Oxygen; Phospholipid Ethers; Platelet Activating Factor; Respiration; Swine | 1991 |
Hydrogen peroxide alters signal transduction in human endothelial cells.
Topics: Catalase; Cells, Cultured; Deferoxamine; Endothelium, Vascular; Epoprostenol; Humans; Hydrogen Peroxide; Hydrolysis; Inositol; Inositol Phosphates; Platelet Activating Factor; Signal Transduction; Thrombin | 1991 |
Effects of stroma-free hemoglobin solutions on pulmonary vascular resistance and mediator release in the isolated perfused rabbit lung.
Topics: Animals; Azepines; Catalase; Cattle; Deferoxamine; Diclofenac; Female; Free Radical Scavengers; Hemoglobins; Histamine Release; Iron; Male; Perfusion; Platelet Activating Factor; Pulmonary Circulation; Rabbits; Stimulation, Chemical; Thromboxane B2; Triazoles; Vascular Resistance; Vasoconstriction | 1994 |
Effect of a platelet-activating factor antagonist and desferrioxamine administration on eicosanoid production in rat pancreas transplantation.
Topics: Animals; Deferoxamine; Diterpenes; Eicosanoids; Ginkgolides; Lactones; Male; Pancreas Transplantation; Platelet Activating Factor; Rats; Rats, Sprague-Dawley; Reperfusion Injury | 1994 |
The effects of free oxygen radical scavenger and platelet-activating factor antagonist agents in experimental acute pancreatitis.
Topics: Acute Disease; Amylases; Animals; Ceruletide; Deferoxamine; Disease Models, Animal; Edema; Free Radical Scavengers; Ginkgo biloba; Inflammation; Leukocytes; Luminescent Measurements; Male; Mice; Pancreas; Pancreatitis; Phytotherapy; Plants, Medicinal; Platelet Activating Factor | 1999 |
Platelet-activating factor enhances the expression of vascular endothelial growth factor in normal human astrocytes.
Topics: Anti-Inflammatory Agents; Astrocytes; Brain; Cells, Cultured; Cycloheximide; Deferoxamine; Dexamethasone; Dose-Response Relationship, Drug; Endothelial Growth Factors; Gene Expression Regulation; Humans; Hypoxia, Brain; Iron Chelating Agents; Lymphokines; Nerve Degeneration; Neurons; Platelet Activating Factor; Protein Synthesis Inhibitors; RNA, Messenger; Time Factors; Up-Regulation; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2002 |
Platelet-activating factor enhances the expression of nerve growth factor in normal human astrocytes under hypoxia.
Topics: Astrocytes; Cell Hypoxia; Cell Survival; Cells, Cultured; Deferoxamine; Diterpenes; Dose-Response Relationship, Drug; Drug Interactions; Enzyme-Linked Immunosorbent Assay; Gene Expression Regulation; Ginkgolides; Glial Fibrillary Acidic Protein; Humans; Iron Chelating Agents; Lactones; Nerve Growth Factors; Platelet Activating Factor; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Time Factors | 2005 |